11 May 2020

The primary treatment of periodontitis option is to remove the pathogenic biofilm mechanically. However, rapid recolonization of the biofilm after debridement often induces the recurrence of periodontitis in susceptible patients. In such cases, adjunctive therapy is required, e.g. direct administration of antimicrobial, antiseptic or anti-inflammatory agents into the periodontal pocket. Unfortunately, there is no standard protocol for every patient with refractory periodontitis, due to considerable differences in disease phenotype and treatment response between patients.A solution for this problem can be found by tailoring the therapy duration and medication dosage to the requirements of the individual patient. Therefore, a controllable and tunable local delivery system has to be available in order to facilitate personalized medicine in the treatment of periodontal disease.

In the Journal of Controlled ReleaseFang Yang, theme Reconstructive and regenerative medicine, and colleagues, have designed and formulated a tunable and injectable local delivery system by loading the PLGA-drug microspheres into the PIC hydrogel. This system exhibited appropriate injectability, long-term structural stability, and no obvious in vivo inflammatory response. Furthermore, the release of drugs could be controlled by adjusting the loaded mass ratio of acid- and ester- end capped PLGA microspheres.

As evidenced in these results, they envision that upon further optimization, this novel and simple thermo-responsive PLGA-PIC carrier system may have the potential to be translated as an effective therapy for penalized medicine in periodontal clinics.

Related news items


Radboudumc research most lungs recover well after COVID-19

26 November 2020

In severe COVID-19 patients the lung tissue recovers well in most cases. This is shown in research by the Radboudumc, published in Clinical Infectious Diseases. Striking conclusion: patients who were referred by the general practitioner recover worse than ICU patients.

read more

Marianne Boenink has been appointed professor in Ethics of Healthcare

26 November 2020

Health scientist and philosopher Marianne Boenink has been appointed professor in Ethics of Healthcare at the Radboud University/ Radboudumc, as of 1 August 2020.

read more

The effects of the COVID-19 pandemic on (future) parents and their babies

26 November 2020

While the corona crisis affects all of us, people who have just started a family or are trying to, are doing this in a sub-optimal situation. Researchers are trying to find out how the ongoing crisis is affecting them.

read more

COVID-19 and the kidney overview of papers

26 November 2020

Within the research theme Renal Disorders several studies were initiated to contribute to the knowledge on COVID-19. Check out our overview of the papers that originated from these studies.

read more

Hydroxychloroquine against malaria appears to block 'trained immunity'

25 November 2020

Raphaël Duivenvoorden and colleagues have discovered an as yet unknown effect of hydroxychloroquine, which are published in Cell Reports Medicine.

read more

NWO XS awarded to identify X inactivation proteins

24 November 2020

NWO XS awarded to the lab of Hendrik Marks for identification of proteins that inactivate the female X chromosome.

read more